Phase I Clinical Trial of CT0180 Cells in the Treatment of Hepatocellular Carcinoma

NCT04756648 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Advanced Hepatocellular Carcinoma

Interventions

DRUG: CT0180 Cells

Sponsor

Zhejiang University

Collaborators

[object Object]